The significant miss in both adjusted EPS and sales compared to analyst estimates is likely to negatively impact investor sentiment and could lead to a short-term decrease in AOMR's stock price. The miss in earnings by such a large margin (244.44%) is particularly concerning and indicates operational challenges. Additionally, missing sales estimates, even by a smaller margin (8.46%), further compounds the negative outlook. However, the 11.20% year-over-year increase in sales might offer some mitigating context, but it's unlikely to offset the negative impact of the earnings miss in the short term.